Sign in
Taking peoplePhase 4

Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE

Key facts

Who runs it
Region Örebro County
Where
Denmark, Sweden, and United Kingdom3 sites in 3 countriesChoose a country to see its sites
Trial code
Status
Recruiting
Phase
Phase 4
People taking part
90 people, planned
Started
24 Apr 2024
Expected to end
Dec 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Influenza vaccine
  • Placebo
Record updated
7 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • Patients with a diagnosis of non-ST-segment elevation myocardial infarction
  • A finalized coronary PCI
  • Male or non-fertile female subjects ≥18 years. (Females without childbearing potential, postmenopausal women and women with a history of hysterectomy or other medical conditions that preclude pregnancy)
  • Written informed consent
  • A CCTA can be scheduled within 7 days after PCI

Who cannot take part

  • Has received influenza vaccination within 6 months
  • Severe allergy to eggs or previous allergic reaction to influenza vaccine
  • Previous randomization in the ELIMINATE trial
  • Other vaccination planned within 8 weeks (including covid-19 booster doses)
  • Cardiac surgery or staged PCI planned within 8 weeks
  • Suspicion of febrile illness or acute, ongoing infection
  • Hypersensitivity to the active substances or ingredients of Vaxigrip or against any residues, such as eggs (ovalbumin or chicken proteins), neomycin, formaldehyde and octoxinol
  • Any non-cardiovascular condition, e.g. malignancy, with a life expectancy of less than 1 year based on the investigator´s clinical judgement
  • Uncontrolled chronic inflammatory disease
  • Contraindication to coronary CT angiography (e.g., inability to lie flat, contraindication to glyceryl trinitrate, previous contrast allergy or contrast-induced nephropathy, severe renal impairment [eGFR <30 mL/min/1.73 m2])
  • Coronary stent involving the proximal RCA
  • Subjects with endogenic or iatrogenic immunosuppression that may result in reduced immunization response
  • Inability to provide informed consent
  • Atrial fibrillation
  • Unable to comply with protocol requirements

This trial has no sites in United States.

It has sites in 3 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this randomized, double-blind, placebo-controlled clinical trial is to investigate the immunological effects of influenza vaccination outside of the influenza season on arterial inflammation in patients with a recent acute myocardial infarction (AMI). The primary objective is to compare the effects of influenza vaccination to those of a placebo in reducing post-myocardial infarction coronary inflammation as measured by coronary computed tomography angiography (CCTA). The main questions it aims to answer are:

Read full original descriptionShow less

Does influenza vaccination reduce arterial inflammation as measured by CCTA at week 8 after percutaneous coronary intervention (PCI) in comparison to baseline? Does influenza vaccination modulate systemic inflammation as measured by blood biomarkers and in-vitro challenge tests at week 8 after PCI in comparison to baseline? Researchers will compare the effects of influenza vaccination with those of a placebo.

The 2 groups in the trial

  • Vaccination armExisting treatment, for comparison

    Influenza vaccine (Inactivated, split virus or surface antigen Suspension for injection, prefilled syringe ATC code: J07BB02)

    Treatment: Influenza vaccine

  • Placebo armPlacebo, for comparison

    Sodium Chloride (Placebo) Solution for infusion, 9mg/ml ATC code: B05BB01

    Treatment: Placebo

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE - a Randomized, Double-blind, Placebo-controlled, Trial (ELIMINATE Trial)
Record updated
7 April 2026